We found that compared to that in the lung of saline-treated mice, nearly 80% of GFP-positive hBMSCs expressed α-SMA in the BLM group at 7 days (Fig. 6A and D, BLM) or at 14 days (Fig. S3A, day14) after BLM administration. This evidence concerns the gene ACTA1 and Bloom syndrome.